查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1614197

內毒素檢測市場：按產品、檢測類型、應用和最終用途分類 - 2025-2030 年全球預測

Endotoxin Testing Market by Offering (Instruments, Reagents & Kits, Software), Test Type (Chromogenic Tests, Gel Clot Tests, Limulus Amebocyte Lysate Test), Application, End-Use - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023 年，內毒素檢測市場價值為 12.2 億美元，預計 2024 年將達到 13.3 億美元，預計複合年成長率為 9.47%，到 2030 年將達到 23 億美元。

內毒素檢測透過檢測可能對人類造成副作用的細菌毒素，在確保藥物、生技藥品和醫療設備的安全性和有效性方面發揮重要作用。內毒素檢測的需要源於嚴格的監管要求，旨在防止注射藥物和植入，這可能導致嚴重的併發症和死亡。應用範圍包括藥品製造、醫療設備製造和生技藥品，最終用途包括醫院、實驗室、生物技術公司和監管機構。內毒素檢測市場的主要促進因素是對生技藥品和生物學名藥的需求不斷成長、製藥業務中對品管的日益關注以及健​​康意識的提高導致監管審查的加強。重組 C 因子 (rFC) 檢測等技術進步提供了避免動物試驗的永續檢測方法，帶來了龐大的商機。生物製藥領域研發投資的增加可能會進一步推動市場成長。然而，測試設備高成本、法律規範複雜以及對熟練人員的需求等挑戰可能會阻礙市場擴張。此外，COVID-19 大流行再形成了市場動態，並暴露了供應鏈缺口，企業必須解決這些缺口才能增強彈性。最新的潛在機會在於實驗室流程的數位化、測試中預測分析的人工智慧整合以及經濟高效的快速檢測套組的廣泛採用。公司可以透過開發自動化內毒素檢測系統或探索與生物技術和製藥公司合作來提供客製化解決方案來進行創新。儘管市場成長看起來強勁，相關人員應優先考慮監管合規和技術創新，以克服現有瓶頸。總體而言，由於對高品質、無污染的醫藥和生物技術產品的需求不斷增加，內毒素檢測市場具有廣泛的擴展和創新潛力。

主要市場統計
基準年[2023] 12.2億美元
預計年份 [2024] 13.3億美元
預測年份 [2030] 23億美元
複合年成長率（%） 9.47%

市場動態：揭示快速發展的內毒素檢測市場的關鍵市場洞察

供需的動態交互作用正在改變內毒素檢測市場。了解這些不斷變化的市場動態可以幫助組織做出明智的投資決策、改善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 世界各地慢性病的盛行率正在上升
    • 快速生產具有成本效益的生技藥品和學名藥
    • 將內毒素檢測整合到藥物開發的各個階段
  • 市場限制因素
    • 與內毒素檢測程序相關的高成本
  • 市場機會
    • 鱟變形細胞裂解物技術的進展
    • 政府強制要求在藥品生產的每個階段使用內毒素檢測
  • 市場挑戰
    • 內毒素檢測溶液檢測結果的變化

波特五力：駕馭內毒素檢測市場的策略工具

波特的五力框架是了解內毒素檢測市場競爭格局的關鍵工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解內毒素檢測市場的外部影響

外部宏觀環境因素對內毒素檢測市場的績效動態起著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解內毒素檢測市場的競爭狀況

內毒素檢測市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣內毒素檢測市場供應商績效評估

FPNV定位矩陣是評估內毒素檢測市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了內毒素檢測市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，內毒素檢測市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 世界各地慢性病盛行率正在上升
      • 由於成本效益，生物製藥和學名藥產量激增
      • 將內毒素檢測整合到藥物開發的不同階段
    • 抑制因素
      • 與內毒素檢測程序相關的高成本
    • 機會
      • 鱟阿米巴細胞裂解物技術的進展
      • 政府強制要求在藥品生產的各個階段使用內毒素檢測
    • 任務
      • 內毒素檢測溶液檢測結果的變化
  • 市場區隔分析
    • 我們提供什麼：利用鱟試劑盒和系統進行內毒素檢測，以確保準確性和法規遵循
    • 應用：增加內毒素檢測的使用，確保臨床用藥的安全性和有效性
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 內毒素檢測市場：依提供方式

  • 裝置
  • 試劑和套件
  • 軟體

第7章依測試類型分類的內毒素檢測市場

  • 顯色試驗
  • 凝膠血液凝固檢驗
  • 鱟血球裂解物試驗
  • 濁度測量測試

第8章內毒素檢測市場：依應用分類

  • 臨床試驗
  • 醫療設備測試
  • 製藥和生物技術測試

第9章內毒素檢測市場：依最終用途分類

  • 合約調查機構
  • 醫院和診斷中心
  • 製藥和生物技術公司
  • 研究/學術機構

第10章 南北美洲內毒素檢測市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太地區內毒素檢測市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章 歐洲、中東和非洲內毒素檢測市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • 透過策略合作內毒素檢測提高生物製藥的準確性
    • Charles River 推出創新的非動物內毒素檢測解決方案
    • 龍沙推出星雲分光光度計，增強內毒素偵測能力
  • 戰略分析和建議

公司名單

  • Accugen Laboratories, Inc.
  • Agilent Technologies, Inc.
  • ARL Bio Pharma
  • Associates of Cape Cod, Inc.
  • Bio-Rad Laboratories, Inc.
  • Bio-Synthesis Inc.
  • BioMerieux SA
  • Charles River Laboratories International, Inc.
  • Eurofins Scientific SE
  • Fujifilm Corporation
  • GenScript Biotech Corporation
  • Labcorp
  • Lonza Group Ltd.
  • Merck KGaA
  • METTLER TOLEDO
  • Nelson Laboratories, LLC by Sotera Health Company
  • Pace Analytical Services, LLC
  • Pacific BioLabs
  • QIAGEN NV
  • SGS SA
  • Thermo Fisher Scientific Inc.
  • Waters Corporation
  • WuXi AppTec Co., Ltd.
Product Code: MRR-CB04E05657E7

The Endotoxin Testing Market was valued at USD 1.22 billion in 2023, expected to reach USD 1.33 billion in 2024, and is projected to grow at a CAGR of 9.47%, to USD 2.30 billion by 2030.

Endotoxin testing serves a critical role in ensuring the safety and efficacy of pharmaceuticals, biologics, and medical devices by detecting bacterial toxins that could trigger adverse reactions in humans. The necessity of endotoxin testing arises from stringent regulatory requirements aimed at preventing contamination in injectable drugs and implants, which could result in severe complications or even fatalities. Applications are broad, spanning pharmaceutical manufacturing, medical device production, and biologics, with end-use sectors including hospitals, research laboratories, biotechnology firms, and regulatory bodies. The market for endotoxin testing is primarily driven by the escalating demand for biologics and biosimilars, heightened focus on quality control in pharmaceutical operations, and rising health awareness that increases regulatory scrutiny. Technological advancements like the recombinant Factor C (rFC) assay, which offers sustainable testing methods avoiding animal testing, present significant opportunities. Increasing R&D investments in the biopharmaceutical sector can further bolster market growth. However, challenges such as the high cost of testing instruments, complex regulatory frameworks, and the need for skilled personnel could impede market expansion. Furthermore, the COVID-19 pandemic has reshaped market dynamics, illuminating gaps in the supply chain that companies should address to enhance resilience. The newest potential opportunities lie in the digital transformation of laboratory processes, integration of artificial intelligence for predictive analytics in testing, and enhancing the adoption of cost-effective, rapid testing kits. Companies can innovate by developing automated endotoxin testing systems and exploring partnerships with biotech and pharma firms for tailored solutions. While market growth appears robust, stakeholders should prioritize regulatory compliance and technological innovation to overcome existing bottlenecks. Overall, as the demand for high-quality, contamination-free pharmaceutical and biotechnology products increases, the endotoxin testing market holds promising potential for expansion and innovation.

KEY MARKET STATISTICS
Base Year [2023] USD 1.22 billion
Estimated Year [2024] USD 1.33 billion
Forecast Year [2030] USD 2.30 billion
CAGR (%) 9.47%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Endotoxin Testing Market

The Endotoxin Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of chronic illnesses across the globe
    • Surge in biologics and generics production due to their cost-effectiveness
    • Integration of endotoxin testing across different stages of drug development
  • Market Restraints
    • High costs associated with endotoxin testing procedures
  • Market Opportunities
    • Advancements in Limulus Amebocyte Lysate technology
    • Government mandates for use of endotoxin testing across stages of pharmaceutical production
  • Market Challenges
    • Variability in test results of endotoxin testing solutions

Porter's Five Forces: A Strategic Tool for Navigating the Endotoxin Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Endotoxin Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Endotoxin Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Endotoxin Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Endotoxin Testing Market

A detailed market share analysis in the Endotoxin Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Endotoxin Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Endotoxin Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Endotoxin Testing Market

A strategic analysis of the Endotoxin Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Endotoxin Testing Market, highlighting leading vendors and their innovative profiles. These include Accugen Laboratories, Inc., Agilent Technologies, Inc., ARL Bio Pharma, Associates of Cape Cod, Inc., Bio-Rad Laboratories, Inc., Bio-Synthesis Inc., BioMerieux SA, Charles River Laboratories International, Inc., Eurofins Scientific SE, Fujifilm Corporation, GenScript Biotech Corporation, Labcorp, Lonza Group Ltd., Merck KGaA, METTLER TOLEDO, Nelson Laboratories, LLC by Sotera Health Company, Pace Analytical Services, LLC, Pacific BioLabs, QIAGEN N.V., SGS SA, Thermo Fisher Scientific Inc., Waters Corporation, and WuXi AppTec Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Endotoxin Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Offering, market is studied across Instruments, Reagents & Kits, and Software.
  • Based on Test Type, market is studied across Chromogenic Tests, Gel Clot Tests, Limulus Amebocyte Lysate Test, and Turbidimetric Tests.
  • Based on Application, market is studied across Clinical Testing, Medical Device Testing, and Pharmaceutical & Biotechnology Testing.
  • Based on End-Use, market is studied across Contract Research Organizations, Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, and Research & Academic Institutes.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of chronic illnesses across the globe
      • 5.1.1.2. Surge in biologics and generics production due to their cost-effectiveness
      • 5.1.1.3. Integration of endotoxin testing across different stages of drug development
    • 5.1.2. Restraints
      • 5.1.2.1. High costs associated with endotoxin testing procedures
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in Limulus Amebocyte Lysate technology
      • 5.1.3.2. Government mandates for use of endotoxin testing across stages of pharmaceutical production
    • 5.1.4. Challenges
      • 5.1.4.1. Variability in test results of endotoxin testing solutions
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Offering: Utilization of LAL test cartridges and systems in endotoxin testing to ensure the accuracy and regulatory compliance
    • 5.2.2. Application: Increasing usage of endotoxin testing to ensure the safety and efficacy of medical and pharmaceutical products in clinical settings
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Endotoxin Testing Market, by Offering

  • 6.1. Introduction
  • 6.2. Instruments
  • 6.3. Reagents & Kits
  • 6.4. Software

7. Endotoxin Testing Market, by Test Type

  • 7.1. Introduction
  • 7.2. Chromogenic Tests
  • 7.3. Gel Clot Tests
  • 7.4. Limulus Amebocyte Lysate Test
  • 7.5. Turbidimetric Tests

8. Endotoxin Testing Market, by Application

  • 8.1. Introduction
  • 8.2. Clinical Testing
  • 8.3. Medical Device Testing
  • 8.4. Pharmaceutical & Biotechnology Testing

9. Endotoxin Testing Market, by End-Use

  • 9.1. Introduction
  • 9.2. Contract Research Organizations
  • 9.3. Hospitals & Diagnostic Centers
  • 9.4. Pharmaceutical & Biotechnology Companies
  • 9.5. Research & Academic Institutes

10. Americas Endotoxin Testing Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Endotoxin Testing Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Endotoxin Testing Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Enhanced Precision in Biopharmaceutical Endotoxin Testing Through Strategic Collaboration
    • 13.3.2. Charles River Launches Innovative Animal-Free Rapid Endotoxin Testing Solution
    • 13.3.3. Lonza Introduces the Nebula Absorbance Reader for Enhanced Endotoxin Detection
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Accugen Laboratories, Inc.
  • 2. Agilent Technologies, Inc.
  • 3. ARL Bio Pharma
  • 4. Associates of Cape Cod, Inc.
  • 5. Bio-Rad Laboratories, Inc.
  • 6. Bio-Synthesis Inc.
  • 7. BioMerieux SA
  • 8. Charles River Laboratories International, Inc.
  • 9. Eurofins Scientific SE
  • 10. Fujifilm Corporation
  • 11. GenScript Biotech Corporation
  • 12. Labcorp
  • 13. Lonza Group Ltd.
  • 14. Merck KGaA
  • 15. METTLER TOLEDO
  • 16. Nelson Laboratories, LLC by Sotera Health Company
  • 17. Pace Analytical Services, LLC
  • 18. Pacific BioLabs
  • 19. QIAGEN N.V.
  • 20. SGS SA
  • 21. Thermo Fisher Scientific Inc.
  • 22. Waters Corporation
  • 23. WuXi AppTec Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. ENDOTOXIN TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. ENDOTOXIN TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ENDOTOXIN TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS ENDOTOXIN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS ENDOTOXIN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES ENDOTOXIN TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES ENDOTOXIN TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC ENDOTOXIN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC ENDOTOXIN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ENDOTOXIN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ENDOTOXIN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. ENDOTOXIN TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. ENDOTOXIN TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ENDOTOXIN TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ENDOTOXIN TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ENDOTOXIN TESTING MARKET DYNAMICS
  • TABLE 7. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY CHROMOGENIC TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY GEL CLOT TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY LIMULUS AMEBOCYTE LYSATE TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY TURBIDIMETRIC TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY CLINICAL TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY MEDICAL DEVICE TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS ENDOTOXIN TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES ENDOTOXIN TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC ENDOTOXIN TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. AUSTRALIA ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. CHINA ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. CHINA ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. INDIA ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. INDIA ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. INDONESIA ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. INDONESIA ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. JAPAN ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. JAPAN ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. MALAYSIA ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. MALAYSIA ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. PHILIPPINES ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. PHILIPPINES ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. SINGAPORE ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. SINGAPORE ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH KOREA ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH KOREA ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. TAIWAN ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. TAIWAN ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. THAILAND ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. THAILAND ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. VIETNAM ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. VIETNAM ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA ENDOTOXIN TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. DENMARK ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. DENMARK ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. EGYPT ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. EGYPT ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. FINLAND ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. FINLAND ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. FRANCE ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. FRANCE ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. GERMANY ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. GERMANY ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. ISRAEL ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. ISRAEL ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. ITALY ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. ITALY ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. NETHERLANDS ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. NIGERIA ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. NIGERIA ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. NORWAY ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. NORWAY ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. POLAND ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 152. POLAND ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. QATAR ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 156. QATAR ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. RUSSIA ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. RUSSIA ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 164. SAUDI ARABIA ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH AFRICA ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. SPAIN ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. SPAIN ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. SWEDEN ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 176. SWEDEN ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. SWITZERLAND ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. TURKEY ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 184. TURKEY ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED ARAB EMIRATES ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED KINGDOM ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 193. ENDOTOXIN TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 194. ENDOTOXIN TESTING MARKET, FPNV POSITIONING MATRIX, 2023